Boston Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boston Family Office’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,251	Closed	-$354K	–	263
2023 Q2	$354K	Sell	4,251 -3,024	-42%	-$253K	0.03%	219
2023 Q1	$554K	Sell	7,275 -2,195	-23%	-$182K	0.04%	183
2022 Q4	$786K	Sell	9,470 -11,364	-55%	-$920K	0.07%	168
2022 Q3	$1.65M	Sell	20,834 -19,010	-48%	-$1.6M	0.15%	115
2022 Q2	$2.96M	Sell	39,844 -48,074	-55%	-$3.61M	0.25%	82
2022 Q1	$7.9M	Buy	87,918 +4,805	+6%	+$444K	0.56%	54
2021 Q4	$9.3M	Buy	83,113 +9,587	+13%	+$1.16M	0.61%	51
2021 Q3	$9.24M	Buy	73,526 +2,090	+3%	+$269K	0.67%	46
2021 Q2	$9.67M	Buy	71,436 +7,173	+11%	+$943K	0.69%	46
2021 Q1	$8.51M	Buy	64,263 +2,485	+4%	+$372K	0.64%	52
2020 Q4	$8.7M	Sell	61,778 -924	-1%	-$118K	0.67%	51
2020 Q3	$6.99M	Sell	62,702 -389	-0.6%	-$43.6K	0.63%	48
2020 Q2	$7.06M	Buy	63,091 +3,182	+5%	+$313K	0.69%	46
2020 Q1	$4.64M	Buy	59,909 +31	+0.1%	+$2.75K	0.55%	53
2019 Q4	$5.7M	Sell	59,878 -2,450	-4%	-$212K	0.54%	54
2019 Q3	$4.75M	Sell	62,328 -1,194	-2%	-$99.2K	0.49%	57
2019 Q2	$5.57M	Sell	63,522 -1,298	-2%	-$111K	0.58%	53
2019 Q1	$5.87M	Buy	64,820 +32,081	+98%	+$2.73M	0.63%	52
2018 Q4	$2.35M	Sell	32,739 -3,267	-9%	-$263K	0.29%	90
2018 Q3	$3.45M	Buy	36,006 +3,856	+12%	+$374K	0.36%	83
2018 Q2	$3.06M	Buy	+32,150	New	+$2.95M	0.35%	84

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Boston Family Office's XBI Position: Q3 2023 in Review

Boston Family Office sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 4,251 shares — an estimated $354K sold.

Boston Family Office first reported a position in XBI in Q2 2018 and held it in 21 quarters. The position peaked at $9.67M in Q2 2021. 677 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Boston Family Office reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Boston Family Office sold 4,251 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $354K.
Boston Family Office first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 21 quarters.
Boston Family Office's State Street SPDR S&P Biotech ETF position peaked at $9.67M in Q2 2021.
677 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Boston Family Office's 13F filing for Q3 2023, filed 13 Nov 2023.